Based on the electronical poll in December 2021, we are happy to announce the new members of the European MCL board (in alphabetical order):

• Martin Dreying, Munich, Germany
• Simone Ferrero, Torino, Italy
• Eva Gine, Barcelona, Spain
• Mats Jerkeman, Lund, Sweden
• Vincent Ribrag, Paris, France

During the annual meeting in Paris, October 28-30, the Czernecki Donnelly Prize 2021 has been awarded to Silvia Bea, Hospital Clinic Barcelona, for her work

Ferran Nadeu#, et al, Sílvia Beà*, Elias Campo*. Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020 Sep 17;136(12):1419-1432.

We invite you to apply for the above mentioned award which is endowed with 5.000 €.

Preferably younger investigators should submit:

• full manuscript focussing on basic science, translational or clinical aspects of mantle cell lymphoma published in 2020
• structured cv including a list of publications and other grants of the applicant
• application letter

All submissions will be evaluated by the Board of the European MCL Network. Grantees will be announced at the 26th annual EHA congress in Vienna during the session of the EHA LyG scientific working group.

Awardees are invited to present their work during the next annual conference of the European MCL network.
Please send your applications until April 1st 2021 to: info@european-mcl.net

The 1st Czernecki Donnelly Prize of the European MCL Network was awarded to Elisabeth Silkenstedt on the EHA 25 virtual for her work "Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy" (Journal of Experimental & Clinical Cancer Research (2019) 38: 446).